NO20000573D0 - Kjemiske forbindelser - Google Patents

Kjemiske forbindelser

Info

Publication number: NO20000573D0
Authority: NO; Norway
Prior art keywords: sup; formula; chemical connections; mcp; disease
Prior art date: 1997-08-07

Application number

NO20000573A

Other languages

English (en)

Other versions

NO20000573L (no

Inventor

Andrew John Barker

Jason Grant Kettle

Alan Wellington Faull

Original Assignee

Zeneca Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-07

Filing date

2000-02-04

Publication date

2000-02-04

2000-02-04 Application filed by Zeneca Ltd filed Critical Zeneca Ltd

2000-02-04 Publication of NO20000573D0 publication Critical patent/NO20000573D0/no

2000-02-04 Publication of NO20000573L publication Critical patent/NO20000573L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Orthopedic Medicine & Surgery (AREA)
Vascular Medicine (AREA)
Toxicology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Indole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)
External Artificial Organs (AREA)
Mechanical Coupling Of Light Guides (AREA)

NO20000573A 1997-08-07 2000-02-04 Kjemiske forbindelser NO20000573L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9716657.3A GB9716657D0 (en)	1997-08-07	1997-08-07	Chemical compounds
PCT/GB1998/002341 WO1999007351A2 (en)	1997-08-07	1998-08-04	Indole derivatives and their use as mcp-1 antagonists

Publications (2)

Publication Number	Publication Date
NO20000573D0 true NO20000573D0 (no)	2000-02-04
NO20000573L NO20000573L (no)	2000-02-04

Family

ID=10817097

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20000573A NO20000573L (no)	1997-08-07	2000-02-04	Kjemiske forbindelser

Country Status (27)

Country	Link
US (2)	US6441004B1 (no)
EP (1)	EP1003504B1 (no)
JP (1)	JP3863722B2 (no)
KR (1)	KR20010022318A (no)
CN (1)	CN1265591A (no)
AT (1)	ATE244007T1 (no)
AU (1)	AU745907C (no)
BR (1)	BR9811818A (no)
CA (1)	CA2297290A1 (no)
CZ (1)	CZ294600B6 (no)
DE (1)	DE69816091T2 (no)
DK (1)	DK1003504T3 (no)
ES (1)	ES2201517T3 (no)
GB (1)	GB9716657D0 (no)
HR (1)	HRP20000061A2 (no)
HU (1)	HUP0004301A3 (no)
ID (1)	ID23666A (no)
IL (1)	IL133989A0 (no)
NO (1)	NO20000573L (no)
NZ (1)	NZ502056A (no)
PL (1)	PL338948A1 (no)
PT (1)	PT1003504E (no)
RU (1)	RU2217142C2 (no)
SK (1)	SK284408B6 (no)
TR (1)	TR200000289T2 (no)
WO (1)	WO1999007351A2 (no)
ZA (1)	ZA987090B (no)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9716657D0 (en) *	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
FR2768146B1 (fr) *	1997-09-05	2000-05-05	Oreal	Nouveaux composes de la famille des indole-carboxyliques et leur utilisation
GB9902459D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902452D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902455D0 (en) *	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902453D0 (en) *	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902461D0 (en) *	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
FR2796279B1 (fr) *	1999-07-16	2001-09-21	Oreal	Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour le traitement de la seborrhee
FR2796274B1 (fr) *	1999-07-16	2001-09-21	Oreal	Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
GB0000626D0 (en) *	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds
GB0000625D0 (en)	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds
KR20030036917A (ko)	2000-10-10	2003-05-09	스미스클라인 비참 코포레이션	치환된 인돌, 이를 함유하는 약제학적 조성물, 및 이의ＰＰＡＲ-γ결합제로서의 용도
HUP0303540A2 (hu)	2000-12-20	2004-01-28	Bristol-Myers Squibb Pharma Co.	Diaminok mint kemokin receptor aktivitás modulátorai, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
CA2432369A1 (en)	2000-12-20	2002-08-08	Bristol-Myers Squibb Pharma Company	Cyclic derivatives as modulators of chemokine receptor activity
JP2004529113A (ja)	2001-03-07	2004-09-24	ファイザー・プロダクツ・インク	ケモカイン受容体活性のモジュレーター
ES2180436B1 (es) *	2001-06-04	2003-11-01	Menarini Lab	Nuevos indoles como inhibidores de la ciclooxigenasa- ii
EP1314733A1 (en) *	2001-11-22	2003-05-28	Aventis Pharma Deutschland GmbH	Indole-2-carboxamides as factor Xa inhibitors
US7589199B2 (en)	2002-06-12	2009-09-15	Chemocentryx, Inc.	Substituted piperazines
US7842693B2 (en)	2002-06-12	2010-11-30	Chemocentryx, Inc.	Substituted piperazines
DK1531822T3 (da)	2002-06-12	2009-12-07	Chemocentryx Inc	1-aryl-4-substituerede piperazin derivater til anvendelse som CCR1 antagonister til behandlingen af inflammation og immunforstyrrelser
US7338975B2 (en)	2003-02-12	2008-03-04	Bristol-Myers Squibb Co.	Lactams as modulators of chemokine receptor activity
TW200508224A (en)	2003-02-12	2005-03-01	Bristol Myers Squibb Co	Cyclic derivatives as modulators of chemokine receptor activity
MXPA05009771A (es)	2003-03-14	2005-10-26	Ono Pharmaceutical Co	Derivados heterociclicos que contienen nitrogeno y medicamentos que los contienen como el ingrediente activo.
WO2004092322A2 (en) *	2003-04-14	2004-10-28	Surface Logix, Inc.	Devices and assays for monitoring/measuring cellular dynamics to create subject profiles from primary cells
JP4710606B2 (ja)	2003-04-18	2011-06-29	小野薬品工業株式会社	スピロピペリジン化合物およびその医薬用途
US7291615B2 (en)	2003-05-01	2007-11-06	Bristol-Myers Squibb Company	Cyclic derivatives as modulators of chemokine receptor activity
US7230133B2 (en)	2003-05-01	2007-06-12	Bristol-Myers Squibb Company	Malonamides and malonamide derivatives as modulators of chemokine receptor activity
US7732162B2 (en)	2003-05-05	2010-06-08	Probiodrug Ag	Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
WO2004108671A1 (en) *	2003-06-06	2004-12-16	Suven Life Sciences Limited	Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them
SE0302035D0 (sv) *	2003-07-09	2003-07-09	Biolipox Ab	New compound
US7332521B2 (en) *	2003-09-25	2008-02-19	Wyeth	Substituted indoles
US7230022B2 (en)	2004-02-19	2007-06-12	Bristol-Myers Squibb Company	Substituted fused bicyclic amines as modulators of chemokine receptor activity
US7381738B2 (en)	2004-02-19	2008-06-03	Bristol-Myers Squibb Company	Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
US7288563B2 (en)	2004-02-19	2007-10-30	Bristol-Myers Squibb Company	Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
US7479496B2 (en)	2004-02-19	2009-01-20	Bristol-Myers Squibb Company	Substituted spiro azabicyclics as modulators of chemokine receptor activity
US7435831B2 (en)	2004-03-03	2008-10-14	Chemocentryx, Inc.	Bicyclic and bridged nitrogen heterocycles
JP4845873B2 (ja)	2004-03-03	2011-12-28	ケモセントリックスインコーポレーティッド	二環式および架橋した窒素複素環
WO2005101002A1 (en) *	2004-04-13	2005-10-27	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 2 (ccr2)
US8481035B2 (en)	2004-04-27	2013-07-09	Northwestern University	Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A
ATE405549T1 (de) *	2004-06-18	2008-09-15	Biolipox Ab	Zur behandlung von entzündungen geeignete indole
DE602005011452D1 (de) *	2004-06-18	2009-01-15	Biolipox Ab	Zur behandlung von entzündungen geeignete indole
US20080146616A1 (en) *	2004-06-18	2008-06-19	Kristofer Olofsson	Indoles Useful in the Treatment of Inflammation
RU2007103834A (ru) *	2004-07-01	2008-08-10	Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния (Us)	Ингибирование взаимодействия pdz-доменов малыми молекулами
SG146673A1 (en)	2004-09-13	2008-10-30	Ono Pharmaceutical Co	Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
GB0428173D0 (en) *	2004-12-23	2005-01-26	Astrazeneca Ab	Compounds
EP1676834A1 (en) *	2004-12-30	2006-07-05	Sanofi-Aventis Deutschland GmbH	Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation
US20100197687A1 (en) *	2005-01-19	2010-08-05	Benjamin Pelcman	Indoles Useful in the Treatment of Inflammation
DE602005026867D1 (de)	2005-01-19	2011-04-21	Biolipox Ab	Entzündungshemmende indol-derivate
US20090048285A1 (en) *	2005-01-19	2009-02-19	Benjamin Pelcman	Pyrrolopyridines Useful in the Treatment of Inflammation
US20090069384A1 (en) *	2005-01-19	2009-03-12	Biolipox Ab	Thienopyrroles useful in the treatment of inflammation
US20080249091A1 (en) *	2005-01-19	2008-10-09	Benjamin Pelcman	Indoles Useful in the Treatment of Inflammation
EP1838669A1 (en) *	2005-01-19	2007-10-03	Biolipox AB	Indoles useful in the treatment of inflammation
JPWO2006129679A1 (ja)	2005-05-31	2009-01-08	小野薬品工業株式会社	スピロピペリジン化合物およびその医薬用途
WO2007049771A1 (ja)	2005-10-28	2007-05-03	Ono Pharmaceutical Co., Ltd.	塩基性基を含有する化合物およびその用途
GB2431927B (en) *	2005-11-04	2010-03-17	Amira Pharmaceuticals Inc	5-Lipoxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en)	2005-11-04	2013-03-19	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
WO2007058322A1 (ja)	2005-11-18	2007-05-24	Ono Pharmaceutical Co., Ltd.	塩基性基を含有する化合物およびその用途
UA95788C2 (en) *	2005-12-15	2011-09-12	Ф. Хоффманн-Ля Рош Аг	Fused pyrrole derivatives
WO2007105637A1 (ja)	2006-03-10	2007-09-20	Ono Pharmaceutical Co., Ltd.	含窒素複素環誘導体およびそれらを有効成分とする薬剤
US7732287B2 (en) *	2006-05-02	2010-06-08	Honeywell International Inc.	Method of forming a body-tie
US8618122B2 (en)	2006-05-16	2013-12-31	Ono Pharmaceutical Co., Ltd.	Compound having acidic group which may be protected, and use thereof
WO2008000407A1 (en)	2006-06-28	2008-01-03	Sanofi-Aventis	Inhibitors of cxcr2
KR20090023645A (ko)	2006-06-28	2009-03-05	사노피-아벤티스	신규한 ｃｘｃｒ2 억제제
WO2008000408A1 (en)	2006-06-28	2008-01-03	Sanofi-Aventis	Cxcr2 antagonists
EP2041073B1 (en)	2006-06-30	2016-07-27	Sanofi	Cxcr2 inhibitors
WO2008016006A1 (fr)	2006-07-31	2008-02-07	Ono Pharmaceutical Co., Ltd.	Composé auquel un groupe cyclique est lié par une liaison spiro et son utilisation
ES2452343T3 (es) *	2006-09-29	2014-04-01	Glaxosmithkline Llc	Compuestos de indol sustituidos
MX2009003762A (es) *	2006-10-05	2009-07-10	Centocor Ortho Biotech Inc	Antagonistas del receptor cc-quimiocina 2 para el tratamiento de fibrosis.
WO2008055945A1 (en)	2006-11-09	2008-05-15	Probiodrug Ag	3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
ATE554085T1 (de)	2006-11-30	2012-05-15	Probiodrug Ag	Neue inhibitoren von glutaminylcyclase
EA200901140A1 (ru)	2007-03-01	2010-04-30	Пробиодруг Аг	Новое применение ингибиторов глутаминилциклазы
EP3243814B1 (en)	2007-04-16	2018-10-17	AbbVie Inc.	7-substituted indole as mcl-1 inhibitors
PL2134685T3 (pl)	2007-04-16	2016-02-29	Abbvie Inc	Pochodne indolu niepodstawione w pozycji 7 jako inhibitory Mcl-1
JP5667440B2 (ja)	2007-04-18	2015-02-12	プロビオドルグエージー	グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
WO2008157179A2 (en) *	2007-06-12	2008-12-24	Genentech, Inc.	N-substituted azaindoles and methods of use
US9855370B2 (en) *	2008-01-08	2018-01-02	Yale University	Compositions and methods for promoting patency of vascular grafts
US7964897B2 (en)	2008-07-22	2011-06-21	Honeywell International Inc.	Direct contact to area efficient body tie process flow
US8546431B2 (en)	2008-10-01	2013-10-01	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
CN102695546B (zh)	2009-09-11	2014-09-10	前体生物药物股份公司	作为谷氨酰胺酰环化酶抑制剂的杂环衍生物
US9181233B2 (en)	2010-03-03	2015-11-10	Probiodrug Ag	Inhibitors of glutaminyl cyclase
US8269019B2 (en)	2010-03-10	2012-09-18	Probiodrug Ag	Inhibitors
JP5945532B2 (ja)	2010-04-21	2016-07-05	プロビオドルグエージー	グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体
US8530670B2 (en)	2011-03-16	2013-09-10	Probiodrug Ag	Inhibitors
WO2013009582A1 (en) *	2011-07-12	2013-01-17	Merck Sharp & Dohme Corp.	TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
US8883857B2 (en)	2012-12-07	2014-11-11	Baylor College Of Medicine	Small molecule xanthine oxidase inhibitors and methods of use
KR102336926B1 (ko)	2014-10-06	2021-12-08	버텍스 파마슈티칼스 인코포레이티드	낭성 섬유증 막횡단 전도도 조절자의 조정제
JP6957468B2 (ja)	2015-12-11	2021-11-02	リサーチインスティチュートアットネイションワイドチルドレンズホスピタル	最適化された患者特異的組織操作血管移植片のためのシステムおよび方法
EP3436446B1 (en)	2016-03-31	2023-06-07	Vertex Pharmaceuticals Incorporated	Modulators of cystic fibrosis transmembrane conductance regulator
UA124708C2 (uk)	2016-09-30	2021-11-03	Вертекс Фармасьютікалз Інкорпорейтед	Модулятор муковісцидозного регулятора трансмембранної провідності, фармацевтичні композиції, способи лікування та спосіб отримання модулятора
EP4252629A3 (en)	2016-12-07	2023-12-27	Biora Therapeutics, Inc.	Gastrointestinal tract detection methods, devices and systems
AU2017371200B2 (en)	2016-12-09	2021-05-06	Vertex Pharmaceuticals Incorporated	Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
EP3554541B1 (en)	2016-12-14	2023-06-07	Biora Therapeutics, Inc.	Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
WO2018191146A1 (en) *	2017-04-10	2018-10-18	Navitor Pharmaceuticals, Inc.	Heteroaryl rheb inhibitors and uses thereof
MA54105A (fr)	2017-06-08	2021-09-15	Vertex Pharma	Méthodes de traitement de la fibrose kystique
MA49631A (fr)	2017-07-17	2020-05-27	Vertex Pharma	Méthodes de traitement de la fibrose kystique
KR102606188B1 (ko)	2017-08-02	2023-11-23	버텍스 파마슈티칼스 인코포레이티드	피롤리딘 화합물을 제조하기 위한 공정
PL3461819T3 (pl)	2017-09-29	2020-11-30	Probiodrug Ag	Inhibitory cyklazy glutaminylowej
US10654829B2 (en)	2017-10-19	2020-05-19	Vertex Pharmaceuticals Incorporated	Crystalline forms and compositions of CFTR modulators
US11465985B2 (en)	2017-12-08	2022-10-11	Vertex Pharmaceuticals Incorporated	Processes for making modulators of cystic fibrosis transmembrane conductance regulator
TWI810243B (zh)	2018-02-05	2023-08-01	美商維泰克斯製藥公司	用於治療囊腫纖化症之醫藥組合物
US11414439B2 (en)	2018-04-13	2022-08-16	Vertex Pharmaceuticals Incorporated	Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
US20220249814A1 (en)	2018-11-19	2022-08-11	Progenity, Inc.	Methods and devices for treating a disease with biotherapeutics
EP4309722A3 (en)	2019-12-13	2024-08-07	Biora Therapeutics, Inc.	Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3557142A (en)	1968-02-20	1971-01-19	Sterling Drug Inc	4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters
US3776923A (en)	1970-01-06	1973-12-04	American Cyanamid Co	2-nitro-4-oxo-4,5,6,7-tetrahydroindole
US3997557A (en)	1974-04-23	1976-12-14	American Hoechst Corporation	Substituted N-aminoalkylpyrroles
DE3115993A1 (de) *	1981-04-13	1982-11-11	Schering Ag, 1000 Berlin Und 4619 Bergkamen	Neue indol-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
US4384994A (en)	1981-10-08	1983-05-24	Merck & Co., Inc.	Renin inhibitory peptides
US4496742A (en)	1981-10-13	1985-01-29	The Upjohn Company	Analogs of 5,6-dihydro PGI2
FR2537974A1 (fr)	1982-12-16	1984-06-22	Adir	Nouveaux derives de thieno (2,3-b) pyrrole, leur procede de preparation et les compositions pharmaceutiques les renfermant
US4529724A (en)	1983-10-11	1985-07-16	Mcneilab, Inc.	6H-indolo[2,1-c][1,4]benzodiazepines and 12-oxo derivatives useful as antihypertensives
DE3342688A1 (de)	1983-11-25	1985-06-05	Siemens AG, 1000 Berlin und 8000 München	Roentgenroehre
FR2565981B1 (fr)	1984-06-15	1986-09-19	Adir	Nouveaux derives de thieno (2,3-b) pyrrole, leur procede de preparation et les compositions pharmaceutiques les renfermant
EP0190224A1 (en)	1984-07-30	1986-08-13	Schering Corporation	PROCESS FOR THE PREPARATION OF CIS, ENDOOCTAHYDROCYCLOPENTA [b] PYRROLE-2-CARBOXYLATE
PH23498A (en) *	1984-08-06	1989-08-16	Sterling Drug Inc	3-carbonyl-1-aminoalkyl-1h-indoles,composition and use thereof
JPS61100565A (ja) *	1984-10-22	1986-05-19	Green Cross Corp:The	インド−ル酢酸誘導体
US4675332A (en)	1984-12-10	1987-06-23	Warner-Lambert Company	Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
ATE41002T1 (de)	1984-12-12	1989-03-15	Merck & Co Inc	Substituierte aromatische sulfonamide, ihre herstellung und diese enthaltende ophthalmische zubereitungen.
US4721725A (en)	1986-01-27	1988-01-26	E. R. Squibb & Sons, Inc.	Aryl-cycloalkyl[b]pyrrole derivatives
IL84796A (en)	1986-12-17	1992-03-29	Merck Frosst Canada Inc	Substituted n-benzyl-indoles and pharmaceutical compositions containing them
US4751231A (en)	1987-09-16	1988-06-14	Merck & Co., Inc.	Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents
DE3907388A1 (de)	1989-03-08	1990-09-13	Kali Chemie Pharma Gmbh	Verfahren zur herstellung von indolcarbonsaeurederivaten
US5272145A (en)	1989-08-22	1993-12-21	Merck Frosst Canada, Inc.	(Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes
NZ234883A (en)	1989-08-22	1995-01-27	Merck Frosst Canada Inc	Quinolin-2-ylmethoxy indole derivatives, preparation and pharmaceutical compositions thereof
DE3943225A1 (de)	1989-12-23	1991-06-27	Schering Ag	Neue ss-carboline, verfahren zu deren herstellung und deren verwendung in arzneimitteln
US5081145A (en)	1990-02-01	1992-01-14	Merck Frosst Canada, Inc.	Indole-2-alkanoic acids compositions of and anti allergic use thereof
US5068234A (en) *	1990-02-26	1991-11-26	Sterling Drug Inc.	3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
US5260322A (en)	1990-10-08	1993-11-09	Merck & Co., Inc.	Angiotension II antagonists in the treatment of hyperuricemia
CA2079374C (en)	1991-09-30	2003-08-05	Merck Frosst Canada Incorporated	(bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5389650A (en)	1991-09-30	1995-02-14	Merck Frosst Canada, Inc.	(Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5190968A (en)	1991-09-30	1993-03-02	Merck Frosst Canada, Inc.	(Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5273980A (en)	1991-09-30	1993-12-28	Merck Frosst Canada Inc.	Bicyclic-azaarylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5290798A (en)	1991-09-30	1994-03-01	Merck Frosst Canada, Inc.	(hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5308850A (en)	1991-09-30	1994-05-03	Merck Frosst Canada, Inc.	(Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
RU2047603C1 (ru) *	1991-12-09	1995-11-10	Матвей Абрамович Рехтер	1-алкил-2-ацилиндолы и способы их получения
US5318985A (en)	1991-12-20	1994-06-07	Merrell Dow Pharmaceuticals Inc.	Potentiation of NMDA antagonists
WO1993016069A1 (en)	1992-02-13	1993-08-19	Merck Frosst Canada Inc.	(azaaromaticalkoxy)indoles as inhibitors of leukotriene biosynthesis
PL175347B1 (pl)	1992-04-03	1998-12-31	Upjohn Co	Trójpierścieniowe heterocykliczne aminy aktywne farmaceutycznie
US5334719A (en)	1992-06-17	1994-08-02	Merck Frosst Canada, Inc.	Bicyclic(azaaromatic)indoles as inhibitors of leukotriene bisynthesis
US5288743A (en)	1992-11-20	1994-02-22	Abbott Laboratories	Indole carboxylate derivatives which inhibit leukotriene biosynthesis
ZA939516B (en)	1992-12-22	1994-06-06	Smithkline Beecham Corp	Endothelin receptor antagonists
US5852046A (en)	1993-08-03	1998-12-22	Hoechst Aktiengesellschaft	Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
EP0639573A1 (de) *	1993-08-03	1995-02-22	Hoechst Aktiengesellschaft	Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
US5401287A (en)	1993-08-19	1995-03-28	Ppg Industries, Inc.	Reduction of nickel sulfide stones in a glass melting operation
US5399699A (en)	1994-01-24	1995-03-21	Abbott Laboratories	Indole iminooxy derivatives which inhibit leukotriene biosynthesis
CZ24197A3 (en)	1994-07-27	1997-08-13	Sankyo Co	Heterocyclic compounds, usable as allosteric efectors in muscarine receptors
US5482960A (en)	1994-11-14	1996-01-09	Warner-Lambert Company	Nonpeptide endothelin antagonists
AU4514496A (en) *	1994-12-13	1996-07-03	Smithkline Beecham Corporation	Novel compounds
US5684032A (en)	1994-12-13	1997-11-04	Smithkline Beecham Corporation	Compounds
NZ306734A (no)	1995-04-04	2000-01-28	Texas Biotechnology Corp
IT1282797B1 (it)	1995-04-21	1998-03-31	Colla Paolo	Pirril-(indolil)-aril-sulfoni e relativo processo di produzione ed impiego nella terapia delle infezioni da virus dell'aids
US5639780A (en)	1995-05-22	1997-06-17	Merck Frosst Canada, Inc.	N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
US5604253A (en)	1995-05-22	1997-02-18	Merck Frosst Canada, Inc.	N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
WO1997012613A1 (en)	1995-10-05	1997-04-10	Warner-Lambert Company	Method for treating and preventing inflammation and atherosclerosis
NZ331843A (en)	1996-02-26	2000-09-29	Advanced Res & Tech Inst	Use of carbonic anhydrase inhibitors for treating macular edema or macular degeneration
JP3540495B2 (ja) *	1996-03-18	2004-07-07	三菱重工業株式会社	水素分離膜
JP2000507556A (ja)	1996-03-28	2000-06-20	スミスクライン・ビーチャム・コーポレイション	ケモカインのカルボン酸インドール阻害剤
US5859044A (en)	1996-07-31	1999-01-12	Pfizer Inc.	β-adrenergic agonists
WO1998006703A1 (en)	1996-08-14	1998-02-19	Warner-Lambert Company	2-phenyl benzimidazole derivatives as mcp-1 antagonists
GB9716656D0 (en) *	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
GB9716657D0 (en) *	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
KR100608472B1 (ko)	1997-12-24	2006-08-09	사노피-아벤티스 도이칠란트 게엠베하	인자 Ｘａ의 억제제로서의 인돌 유도체 및 이를 함유하는 약제학적 조성물
GB9803228D0 (en) *	1998-02-17	1998-04-08	Zeneca Ltd	Chemical compounds
GB9803226D0 (en) *	1998-02-17	1998-04-08	Zeneca Ltd	Chemical compounds
GB9902459D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902452D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902455D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902461D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902453D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB0000625D0 (en)	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds
GB0000626D0 (en)	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds

1997
- 1997-08-07 GB GBGB9716657.3A patent/GB9716657D0/en active Pending
1998
- 1998-08-04 HR HR20000061A patent/HRP20000061A2/hr not_active Application Discontinuation
- 1998-08-04 PL PL98338948A patent/PL338948A1/xx unknown
- 1998-08-04 TR TR2000/00289T patent/TR200000289T2/xx unknown
- 1998-08-04 IL IL13398998A patent/IL133989A0/xx unknown
- 1998-08-04 SK SK167-2000A patent/SK284408B6/sk unknown
- 1998-08-04 ID IDW20000172A patent/ID23666A/id unknown
- 1998-08-04 DK DK98937659T patent/DK1003504T3/da active
- 1998-08-04 AT AT98937659T patent/ATE244007T1/de not_active IP Right Cessation
- 1998-08-04 HU HU0004301A patent/HUP0004301A3/hu unknown
- 1998-08-04 AU AU86381/98A patent/AU745907C/en not_active Ceased
- 1998-08-04 CN CN98807795A patent/CN1265591A/zh active Pending
- 1998-08-04 ES ES98937659T patent/ES2201517T3/es not_active Expired - Lifetime
- 1998-08-04 JP JP2000506944A patent/JP3863722B2/ja not_active Expired - Fee Related
- 1998-08-04 CA CA002297290A patent/CA2297290A1/en not_active Abandoned
- 1998-08-04 WO PCT/GB1998/002341 patent/WO1999007351A2/en not_active Ceased
- 1998-08-04 KR KR1020007000897A patent/KR20010022318A/ko not_active Ceased
- 1998-08-04 NZ NZ502056A patent/NZ502056A/en unknown
- 1998-08-04 RU RU2000105901/15A patent/RU2217142C2/ru not_active IP Right Cessation
- 1998-08-04 US US09/485,061 patent/US6441004B1/en not_active Expired - Fee Related
- 1998-08-04 BR BR9811818-8A patent/BR9811818A/pt not_active IP Right Cessation
- 1998-08-04 DE DE69816091T patent/DE69816091T2/de not_active Expired - Fee Related
- 1998-08-04 EP EP98937659A patent/EP1003504B1/en not_active Expired - Lifetime
- 1998-08-04 PT PT98937659T patent/PT1003504E/pt unknown
- 1998-08-04 CZ CZ2000431A patent/CZ294600B6/cs not_active IP Right Cessation
- 1998-08-06 ZA ZA987090A patent/ZA987090B/xx unknown
2000
- 2000-02-04 NO NO20000573A patent/NO20000573L/no not_active Application Discontinuation
2002
- 2002-07-15 US US10/194,969 patent/US6953809B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69816091T2 (de)	2004-05-19
DE69816091D1 (de)	2003-08-07
CA2297290A1 (en)	1999-02-18
ES2201517T3 (es)	2004-03-16
ATE244007T1 (de)	2003-07-15
US6953809B2 (en)	2005-10-11
BR9811818A (pt)	2000-08-15
CZ294600B6 (cs)	2005-02-16
AU8638198A (en)	1999-03-01
HUP0004301A2 (hu)	2001-12-28
DK1003504T3 (da)	2003-10-13
WO1999007351A3 (en)	1999-05-14
AU745907C (en)	2005-02-17
SK284408B6 (sk)	2005-03-04
EP1003504B1 (en)	2003-07-02
JP2001513494A (ja)	2001-09-04
US20030119830A1 (en)	2003-06-26
HRP20000061A2 (en)	2000-12-31
SK1672000A3 (en)	2000-12-11
EP1003504A2 (en)	2000-05-31
KR20010022318A (ko)	2001-03-15
ZA987090B (en)	1999-02-08
TR200000289T2 (tr)	2000-08-21
US6441004B1 (en)	2002-08-27
HUP0004301A3 (en)	2002-10-28
ID23666A (id)	2000-05-11
NZ502056A (en)	2002-02-01
PT1003504E (pt)	2003-11-28
JP3863722B2 (ja)	2006-12-27
WO1999007351A2 (en)	1999-02-18
CN1265591A (zh)	2000-09-06
NO20000573L (no)	2000-02-04
AU745907B2 (en)	2002-04-11
HK1027979A1 (en)	2001-02-02
GB9716657D0 (en)	1997-10-15
CZ2000431A3 (cs)	2000-05-17
RU2217142C2 (ru)	2003-11-27
PL338948A1 (en)	2000-12-04
IL133989A0 (en)	2001-04-30

Publication	Publication Date	Title
NO20000573D0 (no)	2000-02-04	Kjemiske forbindelser
GB9716656D0 (en)	1997-10-15	Chemical compounds
NO20023932D0 (no)	2002-08-19	Nye forbindelser
SE9902987D0 (sv)	1999-08-24	Novel compounds
NO20026064D0 (no)	2002-12-17	Nye forbindelser
CY1107391T1 (el)	2010-07-28	Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
SE0103836D0 (sv)	2001-11-16	Novel compounds
ID27178A (id)	2001-03-08	Senyawa aminosikloheksil eter dan penggunaannya
CA2260777A1 (en)	1998-02-12	Pentafluorobenzenesulfonamides and analogs
CY1105198T1 (el)	2010-03-03	Παραγωγα πιπepιδινης χρησιμα σαν ανταγωνιστες ccr5 για τη θepαπεια ιου ανθρωπινης ανοσοανεπαρκειας (hiv)
SE0003476D0 (sv)	2000-09-28	Compounds
TR199801614T2 (xx)	1998-11-23	Peptit t�revleri
RU94038063A (ru)	1996-05-27	3-фенилуреидо-азепин-2-оны и -бензазепин-2-оны, способы их получения, промежуточные соединения, фармацевтические композиции и способы лечения
DE69726743D1 (de)	2004-01-22	Peptid analoge, die einen siebengliedrigen lactamring enthalten
ES2049703T3 (es)	1998-09-16	Derivados sulfurados de acidos biliares.

Legal Events

Date	Code	Title	Description
2006-03-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application